leisure time -WSS

leisure time

author：comprehensive 2025-09-06 04:12:54 - browse：6616

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Doctor appointment wait times are getting worse

focus

WSS

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Trump Organization, Michael Cohen agree to settle million

It's time to take a new tack for treating Alzheimer's

4th of July breaks record for highest global temperature ever measured

Australia's humpback populations rebound raising hopes of marine scientists

A new deal aims to ramp up use of AI in rehab care decisions

focus

leisure time

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

4th of July breaks record for highest global temperature ever measured

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New case study details death in closely watched Alzhiemer's trial

United colonoscopy coverage change 'may cost lives,' doctors say

'The View' co

Dobbs anniversary: the lost opportunity of abortion as health care

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

In Memoriam: Notable people who died in 2023

Australia's humpback populations rebound raising hopes of marine scientists

hotspot

New chart reveals military’s vast involvement in Operation Warp Speed

Doctor appointment wait times are getting worse

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

7 people shot in DC, police say

Why is France rioting? What to know about the fatal police shooting of Nahel M

'The View' co

focus

focus

entertainment

entertainment